Roche: Arthur Levinson Resigns From Board Of Directors, Effective Immediately

(RTTNews) - Drugmaker Roche (RHHBY) Thursday said Arthur Levinson has resigned from the Board of Directors, effective immediately. Levinson made this decision to avoid any conflict of interest given his role as Chief Executive Officer at Calico.

Christoph Franz, Chairman of the Board of Directors of Roche, said, "We regret Art's decision but at the same time understand his reasons. The Board has greatly valued Art's focus on patients, his scientific expertise and business leadership during this period of growth for Roche."

Art Levinson, 64, has served as a member of the Roche Board of Directors since 2010 and served as Chairman of Genentech from 1999 to 2014. He joined Genentech in 1980 as a research scientist and later served in various roles. He served as Chief Executive Officer of Genentech from 1995 to 2009.

Since 2013, he has served as Chief Executive Officer of Calico, a company focusing on understanding the process of aging and developing therapies for age-related diseases.